The ultimate goal of curative anti-cancer therapies : inducing an adaptive anti-tumor immune response

Frontiers in Immunology. 2011;2 DOI 10.3389/fimmu.2011.00066


Journal Homepage

Journal Title: Frontiers in Immunology

ISSN: 1664-3224 (Online)

Publisher: Frontiers Media S.A.

LCC Subject Category: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy

Country of publisher: Switzerland

Language of fulltext: English

Full-text formats available: PDF, HTML, ePUB, XML



Wolf Hervé eFridman (INSERM,)
Wolf Hervé eFridman (University Paris Descartes)
Wolf Hervé eFridman (Hôpital Européen Georges Pompidou, AP-HP)
Jean-Luc eTEILLAUD (University Paris Descartes)
Catherine eSautès-Fridman (INSERM,)
Catherine eSautès-Fridman (University Paris Descartes)
Franck ePagès (INSERM,)
Franck ePagès (University Paris Descartes)
Jérôme eGalon (INSERM,)
Jérôme eGalon (University Paris Descartes)
Jérôme eGalon (Hôpital Européen Georges Pompidou, AP-HP)
Jessica eZucman-Rossi (University Paris Descartes)
Jessica eZucman-Rossi (Hôpital Européen Georges Pompidou, AP-HP)
Jessica eZucman-Rossi (INSERM U674)
Eric eTartour (University Paris Descartes)
Eric eTartour (Hôpital Européen Georges Pompidou, AP-HP)
Eric eTartour (PARCC, INSERM U970)
Laurence eZITVOGEL (Institut Gustave Roussy)
Laurence eZITVOGEL (Centre of Clinical Investigations, CBT 507)
Laurence eZITVOGEL (Univsersity Paris Sud)
Laurence eZITVOGEL (INSERM U105)
Guido eKroemer (INSERM,)
Guido eKroemer (University Paris Descartes)
Guido eKroemer (Hôpital Européen Georges Pompidou, AP-HP)
Guido eKroemer (INSERM U105)
Guido eKroemer (INSERM U848)
Guido eKroemer (Metabolomics Platform, Institut Gustave Roussy)


Blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 14 weeks


Abstract | Full Text